RaySearch Laboratories AB (RAY.B) Stock Statistics & Valuation Metrics

RaySearch Laboratories AB has a market cap or net worth of $7.70B. The enterprise value is kr8.73B.

RaySearch Laboratories AB has 28,627,798 shares outstanding. The number of shares has decreased by -2.65% in one year.

RaySearch Laboratories AB’s return on equity (ROE) is 0.23 and return on invested capital (ROIC) is 13.77%.

The current PE Ratio of RaySearch Laboratories AB is 35.1. RaySearch Laboratories AB’s PEG ratio is 0.24.

In the last 12 months, RaySearch Laboratories AB had revenue of 1.19B and earned 203.51M in profits. Earnings per share was 5.94.

In the last 12 months, operating cash flow was 308.68M and capital expenditures -226.46M, giving a free cash flow of 82.22M billion.

RaySearch Laboratories AB pays an annual dividend of kr3, resulting in a dividend yield of 1.34%

RaySearch Laboratories AB upcoming earnings date is Feb 12, 2026, Before Open (Confirmed).

RaySearch Laboratories AB as a current ratio of 1.40, with Debt / Equity ratio of 50.65%

In the past 12 months, RaySearch Laboratories AB has paid 59.35M in taxes.

RaySearch Laboratories AB EV to EBITDA ratio is 12.98, with an EV/FCF ratio of 27.70.

RaySearch Laboratories AB has $322.80M in cash and marketable securities with $411.10M in debt, giving a net cash position of -$88.30M billion.

Gross margin is 91.46%, with operating margin of 21.85%, and net profit margin of 17.07%.

The average price target for RaySearch Laboratories AB is ―, which is 11.43% higher than the current price. The consensus rating is ―